Skip to content

Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. With headquarters in Denmark, Novo Nordisk employs approximately 42,300 people in 75 countries, and markets its products in 180 countries.


Novo Nordisk products have been available in the Vietnamese market since 1992 and established a representative office in Ho Chi Minh City in November 2011. Novo Nordisk has expanded its activities in Vietnam and currently has over 100 employees across the country.
Vietnam is experiencing a rapid rise in the incidence of non-communicable diseases like diabetes due to changing socioeconomic conditions, industrialization and urbanization. Experts believe that there are close to 5 million people with diabetes in Vietnam and estimate that more than 60% remain undiagnosed. Even diagnosed patients are treated sub-optimally and majority of the patients fail to achieve treatment targets.

The Vietnamese Government has rolled-out the Vietnam National Diabetes Prevention Program. To supplement this program, a successful 3 year public-private collaboration program was launched in Vietnam called “Vietnam Diabetes Care Program” (VDCP) from 2013-2015. Novo Nordisk was playing an active role in this program by partnering with the Ministry of Health, supported by key leading hospitals and relevant partners across Vietnam. After 3 years of successful implementation, VDCP has enhanced diabetes knowledge to 2000 physicians and raise awareness on early prevention to millions. Novo Nordisk is committed to enhance quality of diabetes care with Vietnamese partners in the years to come.

To contact the Trade Council please click here